Journal of Clinical Oncology, 32(29), 3257 Journal of Clinical Oncology, 32, 3257-63 Journal of clinical oncology, 32(29), 3257-3263. American Society of Clinical Oncology Journal of Clinical Oncology, 32, 29, pp. 3257-63
Journal of Clinical Oncology, 34, 3, pp. 235-43 Journal of Clinical Oncology, 34, 235-43 Journal of Clinical Oncology, 34(3), 235-U89 Journal of Clinical Oncology, 34(3), 235-U89. American Society of Clinical Oncology
The Journal of Sexual Medicine, 12(9), 1927-1939 Journal of Sexual Medicine, 12(9), 1927-1939. Elsevier Inc. The Journal of Sexual Medicine, 12(9), 1927-1939. Wiley
JNCI: Journal of the National Cancer Institute, 107(4) Journal of the National Cancer Institute, 107(4). Oxford University Press JNCI Journal of the National Cancer Institute
International Journal of Radiation Oncology-Biology-Physics, 92(1), 153-160 International Journal of Radiation Oncology Biology Physics, 92(1), 153-160. Elsevier Inc.
Jama Internal Medicine, 175, 1007-17 JAMA Internal Medicine, 175(6), 1007-1017 JAMA internal medicine, 175(6), 1007-1017. American Medical Association Jama Internal Medicine, 175, 6, pp. 1007-17 JAMA Internal Medicine, 175(6), 1007-1017. American Medical Association
The New England Journal of Medicine, 373, 2499-511 New England Journal of Medicine, 373(26), 2499-2511. MASSACHUSETTS MEDICAL SOC New England Journal of Medicine, 373(26), 2499-2511. Massachussetts Medical Society Schaapveld, M, Aleman, B M P, van Eggermond, A M, Janus, C P M, Krol, A D G, van der Maazen, R W M, Roesink, J, Raemaekers, J M M, de Boer, J P, Zijlstra, J M, van Imhoff, G W, Petersen, E J, Poortmans, P M P, Beijert, M, Lybeert, M L, Mulder, I, Visser, O, Louwman, M W J, Krul, I M, Lugtenburg, P J & van Leeuwen, F E 2015, ' Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma ', New England Journal of Medicine, vol. 373, no. 26, pp. 2499-2511 . https://doi.org/10.1056/NEJMoa1505949 The New England Journal of Medicine, 373, 26, pp. 2499-511 New England Journal of Medicine, 373(26), 2499-2511